Novel urinary biomarkers and their association with urinary heavy metals in chronic kidney disease of unknown aetiology in Sri Lanka: a pilot study

Ceylon Med J. 2017 Dec 26;62(4):210-217. doi: 10.4038/cmj.v62i4.8568.

Abstract

Introduction: Chronic kidney disease of unknown etiology (CKDu) has emerged as a significant public health problem in Sri Lanka. The role of environmental exposure to cadmium and arsenic in the aetiology of CKDu is still unclear. Identification of a panel of novel urinary biomarkers would be invaluable in the study of toxin mediated damage postulated to be the aetiology of CKDu.

Objectives: The aims of this study were to evaluate the profile of novel urinary biomarkers in CKDu patients and identify any association with environmental exposure to heavy metals.

Methods: Thirty seven randomly selected CKDu patients attending a renal clinic in the North Central Province and two control groups namely a farmer group (n=39) and a non-farmer group (n=40) from a non-endemic area were included in this comparative cross sectional study. Urine samples were analyzed for heavy metals and five urinary biomarkers.

Results: CKDu patients had significantly elevated urinary levels of fibrinogen (198.2 ng/mg creatinine p<0.001), clusterin (3479 ng/mg creatinine p<0.001), cystatin-C (5124.8 ng/mg creatinine p<0.001) and β2-microglobulin (9913.4 ng/mg creatinine p<0.001) compared to the control groups. Fibrinogen and β2-microglobulin were the best to discriminate CKDu patients from normal individuals with the receiver operator areas under the curve being 0.867 and 0.853, respectively. Urinary fibrinogen and KIM-1 levels correlated positively with urinary arsenic levels. KIM-1 levels correlated positively with urinary mercury and lead levels but no correlation was seen with urinary cadmium levels.

Conclusions: Fibrinogen and β2-microglobulin have the potential of being a screening tool for detection of CKDu and may aid the early diagnosis of toxin mediated tubular injury in CKDu. Their usefulness need to be further validated in a larger epidemiological study of patients with early stages of CKDu.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Arsenic / urine
  • Biomarkers / urine
  • Cadmium / urine
  • Case-Control Studies
  • Clusterin / urine*
  • Cross-Sectional Studies
  • Cystatin C / urine*
  • Environmental Exposure / adverse effects
  • Female
  • Fibrinogen / urine*
  • Hepatitis A Virus Cellular Receptor 1 / metabolism*
  • Humans
  • Lead / urine
  • Male
  • Mercury / urine
  • Metals, Heavy / toxicity
  • Metals, Heavy / urine*
  • Middle Aged
  • Pilot Projects
  • ROC Curve
  • Renal Insufficiency, Chronic / etiology
  • Renal Insufficiency, Chronic / urine*
  • Sri Lanka
  • beta 2-Microglobulin / urine*

Substances

  • Biomarkers
  • Clusterin
  • Cystatin C
  • HAVCR1 protein, human
  • Hepatitis A Virus Cellular Receptor 1
  • Metals, Heavy
  • beta 2-Microglobulin
  • Cadmium
  • Lead
  • Fibrinogen
  • Mercury
  • Arsenic